SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:oru-6968"
 

Sökning: id:"swepub:oai:DiVA.org:oru-6968" > Budd-Chiari syndrom...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005765naa a2200685 4500
001oai:DiVA.org:oru-6968
003SwePub
008090527s2009 | |||||||||||000 ||eng|
009oai:lup.lub.lu.se:951b0ac1-459a-44c5-b21c-ff1f46f90063
009oai:DiVA.org:uu-153473
009oai:DiVA.org:liu-16408
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-69682 URI
0247 a https://doi.org/10.1111/j.1478-3231.2008.01838.x2 DOI
0247 a https://lup.lub.lu.se/record/13133112 URI
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1534732 URI
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-164082 URI
040 a (SwePub)orud (SwePub)lud (SwePub)uud (SwePub)liu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Rajani, Rupeshu Linköpings universitet,Gastroenterologi och hepatologi,Hälsouniversitetet4 aut0 (Swepub:liu)rupra58
2451 0a Budd-Chiari syndrome in Sweden :b epidemiology, clinical characteristics and survival - an 18-year experience
264 1a Oxford :b Blackwell Munksgaard,c 2009
338 a print2 rdacarrier
520 a BACKGROUND: The exact incidence and prevalence of Budd-Chiari syndrome (BCS) is unknown in the general population. Published reports differ in terms of the clinical characteristics, effects of therapy and survival. AIMS: To investigate the epidemiology, clinical presentation and survival in patients with BCS. METHODS: Retrospective multicentre study in Sweden reviewing the medical records of all patients with BCS 1986-2003, identified from the computerised diagnosis database of 11 hospitals, including all university hospitals and liver transplantation centres. RESULTS: Forty-three patients with BCS were identified, of whom nine (21%) had concomitant portal vein thrombosis. The mean age-standardised incidence and prevalence rates in 1990-2001 were calculated to be 0.8 per million per year and 1.4 per million inhabitants respectively. Myeloproliferative disorders (38%), thrombophilic factors (31%) and oral contraceptives (30%) were common aetiological factors. Two or more risk factors were present in 44%. In 23%, no risk factor was evident. The median follow-up time was 2.7 years. Seventy-two percent were on anticoagulant therapy during follow-up. Transjugular intrahepatic portosystemic shunting, surgical shunting procedures and liver transplantation were performed in 4, 6 and 18 patients respectively. Nineteen patients died. The overall transplantation-free survival at 1, 5 and 10 years was 47, 28 and 17% respectively. CONCLUSIONS: Budd-Chiari syndrome is a rare disorder; the mean age-standardised incidence and prevalence rates in Sweden in 1990-2001 were calculated to be 0.8 per million per year and 1.4 per million inhabitants respectively. The presence of a myeloproliferative disorder was a common aetiological factor in our cohort and about half of the patients had a multifactorial aetiology. The transplantation-free survival was poor.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Gastroenterologi0 (SwePub)302132 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Gastroenterology and Hepatology0 (SwePub)302132 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng
653 a MEDICINE
653 a MEDICIN
653 a Gastroenterology
653 a Gastroenterologi
653 a Medicine
653 a Medicin
653 a hepatic vein thrombosis
653 a Budd-Chiari syndrome
653 a epidemiology
653 a risk factors
653 a prognosis
7001 a Melin, Toru University Hospital, Lund4 aut
7001 a Björnsson, Einaru Sahlgrenska University Hospital, Göteborg4 aut
7001 a Broomé, Ulrikau Karolinska University Hospital, Stockholm4 aut
7001 a Sangfelt, Peru University Uppsala Hospital, Uppsala4 aut
7001 a Danielsson, Åkeu Umea University Hospital, Umeå4 aut
7001 a Gustavsson, Andersu Örebro universitet,Hälsoakademin,University Hospital, Örebro4 aut0 (Swepub:oru)argn
7001 a Grip, Olofu Lund University,Lunds universitet,Enheten för kroniska inflammatoriska och degenerativa sjukdomar,Forskargrupper vid Lunds universitet,Chronic Inflammatory and Degenerative Diseases Research Unit,Lund University Research Groups,Malmö University Hospital, Malmö4 aut0 (Swepub:lu)medf-ogr
7001 a Svensson, Hansu Vrinnevi Hospital, Norrköping4 aut
7001 a Lööf, Larsu Uppsala universitet,Centrum för klinisk forskning, Västerås,Västerås City Hospital, Västerås4 aut0 (Swepub:uu)larsloof
7001 a Wallerstedt, Svenu Östra Hospital, Gothenberg4 aut
7001 a Almer, Svenu Östergötlands Läns Landsting,Linköpings universitet,Gastroenterologi och hepatologi,Hälsouniversitetet,Endokrin- och magtarmmedicinska kliniken US4 aut0 (Swepub:liu)sveal38
7102 a Linköpings universitetb Gastroenterologi och hepatologi4 org
7730 t Liver international (Print)d Oxford : Blackwell Munksgaardg 29:2, s. 253-259q 29:2<253-259x 1478-3223x 1478-3231
8564 u http://dx.doi.org/10.1111/j.1478-3231.2008.01838.xy FULLTEXT
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-6968
8564 8u https://doi.org/10.1111/j.1478-3231.2008.01838.x
8564 8u https://lup.lub.lu.se/record/1313311
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-153473
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-16408

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy